
Carolina Reduzzi/LinkedIn
Aug 21, 2025, 15:37
Carolina Reduzzi: ctDNA Landscape Analysis Post CDK4/6 Inhibitor in HR+/HER2- Metastatic Breast Cancer
Carolina Reduzzi, Assistant Professor of Cancer Biology Research in Medicine and Director of Cristofanilli CTC laboratory at Weill Cornell Medicine, shared a post on LinkedIn:
“ctDNA landscape analysis post CDK4/6 inhibitor in HR+/HER2- metastatic breast cancer — Our new paper is out in Nature Portfolio Springer Nature
Thank you to all who contributed to this multi-institutional consortium analysis!”
More posts featuring Carolina Reduzzi.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 21, 2025, 14:21
Aug 21, 2025, 14:18